Histiocytic Sarcoma (HS)
Also known as: Histiocytic Sarcoma / Histiocytic sarcoma (morphologic abnormality) / Histiocytic sarcoma (disorder) / Nasal T-cell lymphoma / Midline malignant reticulosis / Polymorphic reticulosis / Histiocytosis, Malignant / Malignant histiocytosis (disorder) / Malignant histiocytosis (morphologic abnormality) / Malignant histiocytosis
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB05239 | Cobimetinib | 2 | Recruiting | 1 |
DB14860 | Ensartinib | 2 | Recruiting | 1 |
DB12147 | Erdafitinib | 2 | Recruiting | 1 |
DB15127 | Hydrogen | 2 | Recruiting | 1 |
DB12167 | LY-3023414 | 2 | Recruiting | 1 |
DB14723 | Larotrectinib | 2 | Recruiting | 1 |
DB00480 | Lenalidomide | 2 | Active Not Recruiting | 1 |
DB14123 | Menthol | 2 | Recruiting | 1 |
DB09074 | Olaparib | 2 | Recruiting | 1 |
DB09073 | Palbociclib | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Suspended | 1 |
DB15685 | Selpercatinib | 2 | Recruiting | 1 |
DB11689 | Selumetinib | 2 | Recruiting | 1 |
DB14546 | Sulfate ion | 2 | Recruiting | 1 |
DB12887 | Tazemetostat | 2 | Recruiting | 1 |
DB04960 | Tipifarnib | 2 | Recruiting | 1 |
DB13930 | Ulixertinib | 2 | Recruiting | 1 |
DB08881 | Vemurafenib | 2 | Recruiting | 1 |
DB13104 | X-396 | 2 | Recruiting | 1 |